Month: December 2015

FDA Approves Zurampic To Treat Gout

The FDA today approved lesinurad (Zurampic, AstraZeneca Pharmaceuticals) to treat hyperuricemia associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug that reduces the production of uric acid in the body. Gout is a painful form of arthritis caused by the buildup of too much uric acid in …

FDA Approves Zurampic To Treat Gout Read More »

FDA eases restrictions on blood donations from gay men

Federal health officials are lifting the nation’s 32-year-old lifetime ban on blood donations from gay and bisexual men, but major restrictions will continue to limit who can donate. The Food and Drug Administration announced Monday it will replace the blanket ban with a new policy barring donations from men who have had sex with a …

FDA eases restrictions on blood donations from gay men Read More »

Compounded HT prescriptions increasing

The researchers said unique risks come with compounded HT because of the lack of FDA approval and monitoring.   JoAnn V. Pinkerton JoAnn V. Pinkerton, MD, of the University of Virginia Health System, andGinger D. Constantine, MD, of EndoRheum Consultants LLC in Malvern, Pennsylvania, evaluated a national online survey of 365 independent community pharmacies and 118 compounding pharmacies to …

Compounded HT prescriptions increasing Read More »

Johnson & Johnson Back in Court Over Secretive 2009 Recall of Motrin

NEW BRUNSWICK, NJ–In the spring of 2009, “secret shoppers” across the United States were discreetly buying up thousands of bottles of Motrin from the shelves of retail stores. New Brunswick’s own Johnson & Johnson had, through a private contractor, given them instructions to buyback defective Motrin pills from 5,000 U.S. stores, but not reveal there …

Johnson & Johnson Back in Court Over Secretive 2009 Recall of Motrin Read More »

Babies, mothers possibly exposed to TB at California hospital

A Northern California hospital says hundreds of babies, mothers and employees may have been exposed to a nurse with tuberculosis and that the infants will need an antibiotic treatment. The San Jose Mercury News reports that Santa Clara County officials are trying to track down 350 babies and their parents who may have been exposed to a …

Babies, mothers possibly exposed to TB at California hospital Read More »

FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency. Patients with LAL deficiency (also known as Wolman disease and cholesteryl ester storage disease [CESD]) have no or little LAL enzyme activity. This results in a build-up …

FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients Read More »